Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX Trial

Background  Among medically ill patients treated with thromboprophylaxis, betrixaban was not associated with an increase in major bleeding compared with enoxaparin, but an increase in clinically relevant non-major (CRNM) bleeding was observed. The aim of this analysis is to describe the severity and...

Descripción completa

Detalles Bibliográficos
Autores principales: Yee, Megan K., Gibson, C. Michael, Nafee, Tarek, Kerneis, Mathieu, Daaboul, Yazan, Korjian, Serge, Chi, Gerald, AlKhalfan, Fahad, Hernandez, Adrian F., Hull, Russell D., Cohen, Alexander T., Goldhaber, Samuel Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524922/
https://www.ncbi.nlm.nih.gov/pubmed/31249989
http://dx.doi.org/10.1055/s-0039-1685496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524922/
https://www.ncbi.nlm.nih.gov/pubmed/31249989
http://dx.doi.org/10.1055/s-0039-1685496

Ejemplares similares